NYSE: ALLAllstate Corp Stock
$231.55+8.99 (+4.04%)
Updated Jun 23, 2026
ALL Price
$231.55
Fair Value Price
N/A
Market Cap
$59.61B
52 Week Low
$188.08
52 Week High
$232.36
P/E
5.05x
P/B
1.89x
P/S
0.79x
PEG
N/A
Dividend Yield
1.8%
Revenue
$68.17B
Earnings
$12.14B
Gross Margin
46.9%
Operating Margin
23.41%
Profit Margin
17.6%
Debt to Equity
2.92
Operating Cash Flow
$12B
Beta
0.47
Next Earnings
Aug 5, 2026
Ex-Dividend
N/A
Next Dividend
Jul 1, 2026
ALL Overview
The Allstate Corporation is an insurance company that, operating through multiple brands, offers auto, home, life, and other insurance in the U.S. and Canada. Its segments include Allstate Protection, Run-off Property-Liability, Protection Services, Allstate Health and Benefits, and Corporate and Other. Private auto insurance contributes the largest percentage of the company's revenue. Allstate was founded in 1931 and is based in Northbrook, IL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ALL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Property & Casualty Insurance
Industry Rating
D
ALL
Ranked#7 of 41
Ranked#7 of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $50.24 | B | |
| $106.48 | B | |
| $67.83 | B |
Be the first to know about important ALL news, forecast changes, insider trades & much more!
ALL News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALL is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALL is good value based on its earnings relative to its share price (5.05x), compared to the US market average (7.68x)
P/E vs Market Valuation
ALL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ALL due diligence checks available for Premium users.
Valuation
ALL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
5.05x
Industry
10.56x
Market
7.68x
ALL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ALL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ALL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.89x
Industry
2.02x
ALL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ALL's financial health
Profit margin
Revenue
$16.9B
Net Income
$2.5B
Profit Margin
14.3%
ALL's Earnings (EBIT) of $15.96B... subscribe to Premium to read more.
Interest Coverage Financials
ALL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$124.0B
Liabilities
$92.4B
Debt to equity
2.92
ALL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$3.6B
Investing
-$2.6B
Financing
-$916.0M
ALL's operating cash flow ($11.71B)... subscribe to Premium to read more.
Debt Coverage Financials
ALL vs Property & Casualty Insurance Stocks
Allstate Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.